DSM Pharmaceuticals expands services for formulation development and CTM manufacturing

November 6, 2007 — PARSIPPANY, NJ — DSM Pharmaceuticals Inc., a leading global supplier of pharmaceutical manufacturing services, announces today that it has expanded its service offerings to include formulation development and clinical trial manufacturing (CTM ) for solid dosage form products.

Averaging more than 20 product launches per year, DSM has a 37 year history of successfully manufacturing complex solid dosage forms for the commercial pharmaceutical market. “This expansion of services will have significant value-added
benefits to our customers in terms of reducing cost and accelerating time to market as they will be able to avoid the high cost of tech transfers required for commercial launch by conducting development, CTM and commercial manufacturing all at DSM’s Greenville, NC facilities,” says Terry Novak, president and business unit director of DSM Pharmaceuticals, Inc.

DSM Pharmaceutical Development Services will include:

  • Preformulation
  • Analytical Development
  • Stability studies
  • Formulation Development
  • NCE formulation development
  • Reformulations for line extensions
  • Controlled and Modified release
  • Controlled Substances
  • Clinical Trial Supply


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.